Antisynthetase syndrome (Q35157654)

6 August 2017

1 reference

title

Antisynthetase syndrome. (English)

1 reference

6 August 2017

Agathe Imbert-Masseau

1

1 reference

6 August 2017

Mohamed Hamidou

2

1 reference

6 August 2017

Christian Agard

3

1 reference

6 August 2017

Jean Yves Grolleau

4

1 reference

6 August 2017

Pascal Chérin

5

1 reference

6 August 2017

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

70

1 reference

6 August 2017

3

1 reference

6 August 2017

161-168

1 reference

Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Multiplicity of antibodies in myositis sera

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Autoantibody profiles in the sera of European patients with myositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Dermatomyositis, polymyositis, and Coxsackie-B-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Autoantibodies are anti-idiotype antibodies to antiviral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Severe Perturbations of the Blood T Cell Repertoire in Polymyositis, But Not Dermatomyositis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Spectrum and clinical significance of autoantibodies against transfer RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Antibody to threonyl-transfer RNA synthetase in myositis sera

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Polymyositis, dermatomyositis and inclusion-body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Dermatomyositis and rapidly progressive fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

[Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease]

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

International consensus statement on idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Deforming arthritis of the hands in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Mutilans-like arthropathy in mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Deforming arthritis of the hands: an unusual manifestation of polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

[Vascular manifestations of dermatomyositis and polymyositis. Clinical, capillaroscopic and histological aspects]

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Development and long term prognosis of 50 cases of dermatomyositis and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Cryptogenic fibrosing alveolitis: clinical features and their influence on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

[Intravenous immunoglobulins in polymyositis and dermatomyositis]

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Prednisone and azathioprine for polymyositis: long-term followup.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Tacrolimus in refractory polymyositis with interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900012-5

7 January 2021

10.1016/S1297-319X(03)00012-5

Identifiers

DOI

1 reference

6 August 2017

1 reference